Maya Ancestry May Help Explain the High Risk of Diabetes in Mexico

Emiliano Rodríguez Mega, Science Mag, June 5, 2015

Mexico has one of the highest rates of type 2 diabetes in the world, with 12% of the population suffering from the condition, compared with 9% of people in the United States. The Mexican government is so worried that it recently declared a state of emergency and introduced a tax on soda and junk food. But a new study shows that some Mexicans may be at higher risk for developing diabetes, no matter how healthy their diets are. The reason may be their Maya ancestry, which carries with it genetic variations associated with the disease.

{snip}

There may be fewer Maya today than at the culture’s height 3000 years ago, but they never disappeared. Today, Maya-speaking people constitute the second largest indigenous group in Mexico, with 800,000 people living mainly in the Yucatán Peninsula in the country’s southeast. Isolated culturally and geographically from other ethnicities for thousands of years, the Maya gene pool grew smaller and more homogeneous. As tends to happen with any isolated population, genetic variations that are rare in other groups became common among the Maya. Clinical biochemist Marta Menjívar of the National Autonomous University of Mexico (UNAM) in Mexico City wondered whether any of those variations might increase the Maya’s risk for diabetes, a growing problem in southeastern Mexico.

Menjívar’s team surfed through the genomes of 575 Maya individuals looking for 10 genetic variants that had been previously related to diabetes risk. They found that two are unusually common in the Maya, the researchers will report in next month’s issue of Gene.

The Maya’s relatively homogeneous gene pool made these variations easy to spot, explains Julio César Lara Riegos, a geneticist at UADY and the study’s lead author. But they probably aren’t limited to Maya communities. Most Mexicans are mestizos, with mixed European, African, and indigenous ancestry. The average mestizo has about 55% indigenous ancestry, Menjívar says. That makes studying the genetics of specific indigenous groups vital for understanding risk factors that could be present in the broader Mexican population, says Xavier Soberón, head of Mexico’s National Institute of Genomic Medicine (INMEGEN), who was not involved in the research.

It might also lead to personalized treatments for different Mexican ethnic groups and their mestizo relatives, says Ángeles Granados, a biochemist at UNAM and a co-author of the Gene paper. She is already studying how the Maya’s unique genetic profile may speed up the work of certain enzymes, leading to rapid elimination of diabetes medicines from their bodies. “This could explain at least in part why some diabetics are not well medicated,” she says.

Understanding that process could assist doctors in knowing when to reduce or increase their patients’ doses of these drugs. It could also help Granados and other researchers develop medicines that resist breaking down so quickly and, therefore, would be more effective for Maya patients, as well as for anyone else who shares that particular genetic variant.

{snip}

Topics: , ,

Share This

We welcome comments that add information or perspective, and we encourage polite debate. If you log in with a social media account, your comment should appear immediately. If you prefer to remain anonymous, you may comment as a guest, using a name and an e-mail address of convenience. Your comment will be moderated.